Latest NEA Management Company, LLC Stock Portfolio
NEA Management Company, LLC Performance:
2025 Q2: 13.17%YTD: 10.52%2024: 4.7%
Performance for 2025 Q2 is 13.17%, and YTD is 10.52%, and 2024 is 4.7%.
About NEA Management Company, LLC and 13F Hedge Fund Stock Holdings
NEA Management Company, LLC is a hedge fund based in CHEVY CHASE, MD. On 30-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $25.9 Billions. In it's latest 13F Holdings report, NEA Management Company, LLC reported an equity portfolio of $1.3 Billions as of 30 Jun, 2025.
The top stock holdings of NEA Management Company, LLC are ACLX, VRNA, RYTM. The fund has invested 18.6% of it's portfolio in ARCELLX INC and 16.1% of portfolio in VERONA PHARMA PLC.
The fund managers got completely rid off TEMPUS AI INC, REGULUS THERAPEUTICS INC (RGLS) and DESKTOP METAL INC (DM) stocks. They significantly reduced their stock positions in VERONA PHARMA PLC (VRNA) and X4 PHARMACEUTICALS INC (XFOR). NEA Management Company, LLC opened new stock positions in OMADA HEALTH INC. The fund showed a lot of confidence in some stocks as they added substantially to ORIC PHARMACEUTICALS INC (ORIC), CELCUITY INC (CELC) and TREVI THERAPEUTICS INC (TRVI).
The top stock holdings of NEA Management Company, LLC are ACLX, VRNA, RYTM. The fund has invested 18.6% of it's portfolio in ARCELLX INC and 16.1% of portfolio in VERONA PHARMA PLC.
The fund managers got completely rid off TEMPUS AI INC, REGULUS THERAPEUTICS INC (RGLS) and DESKTOP METAL INC (DM) stocks. They significantly reduced their stock positions in VERONA PHARMA PLC (VRNA) and X4 PHARMACEUTICALS INC (XFOR). NEA Management Company, LLC opened new stock positions in OMADA HEALTH INC. The fund showed a lot of confidence in some stocks as they added substantially to ORIC PHARMACEUTICALS INC (ORIC), CELCUITY INC (CELC) and TREVI THERAPEUTICS INC (TRVI).
NEA Management Company, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that NEA Management Company, LLC made a return of 13.17% in the last quarter. In trailing 12 months, it's portfolio return was 38.3%.
New Buys
| Ticker | $ Bought |
|---|---|
| omada health inc | 6,663,300 |
New stocks bought by NEA Management Company, LLC
Additions
| Ticker | % Inc. |
|---|---|
| oric pharmaceuticals inc | 87.59 |
| celcuity inc | 83.54 |
| trevi therapeutics inc | 16.29 |
| zenas biopharma inc | 4.58 |
Additions to existing portfolio by NEA Management Company, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| verona pharma plc | -15.82 |
| x4 pharmaceuticals inc | 0.00 |
NEA Management Company, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| regulus therapeutics inc | -11,318,700 |
| allakos inc | -1,399,120 |
| tempus ai inc | -126,195,000 |
| buzzfeed inc | -5,350,780 |
| desktop metal inc | -7,069,870 |
| affimed n v | -320,123 |
| tuya inc | 0.00 |
NEA Management Company, LLC got rid off the above stocks
Sector Distribution
NEA Management Company, LLC has about 84.4% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 84.4 |
| Consumer Defensive | 8.5 |
| Others | 7.1 |
Market Cap. Distribution
NEA Management Company, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 54.3 |
| SMALL-CAP | 24.4 |
| MICRO-CAP | 13.1 |
| UNALLOCATED | 7.1 |
| NANO-CAP | 1.1 |
Stocks belong to which Index?
About 64.8% of the stocks held by NEA Management Company, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 64.8 |
| Others | 35.2 |
NEA Management Company, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of NEA Management Company, LLC
NEA Management Company, LLC has 32 stocks in it's portfolio. About 81.3% of the portfolio is in top 10 stocks. CVRX proved to be the most loss making stock for the portfolio. VRNA was the most profitable stock for NEA Management Company, LLC last quarter.
Last Reported on: 14 Aug, 2025| Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACLX | arcellx inc | 18.57 | 3,745,260 | 246,626,000 | unchanged | 0.00 | ||
Historical Trend of ARCELLX INC Position Held By NEA Management Company, LLCWhat % of Portfolio is ACLX?:Number of ACLX shares held:Change in No. of Shares Held: | ||||||||
| VRNA | verona pharma plc | 16.11 | 2,263,140 | 214,048,000 | reduced | -15.82 | ||
| RYTM | rhythm pharmaceuticals inc | 13.84 | 2,909,960 | 183,880,000 | unchanged | 0.00 | ||
| COUR | coursera inc | 8.48 | 12,867,800 | 112,722,000 | unchanged | 0.00 | ||
| CRSP | crispr therapeutics ag | 5.81 | 1,587,850 | 77,233,200 | unchanged | 0.00 | ||
| TRVI | trevi therapeutics inc | 5.44 | 13,222,200 | 72,325,600 | added | 16.29 | ||
| SVRA | savara inc | 4.20 | 24,471,300 | 55,794,500 | unchanged | 0.00 | ||
| ORIC | oric pharmaceuticals inc | 3.15 | 4,118,620 | 41,804,000 | added | 87.59 | ||
| mbx biosciences inc | 3.10 | 3,614,490 | 41,241,300 | unchanged | 0.00 | |||
| GLUE | monte rosa therapeutics inc | 2.61 | 7,692,300 | 34,692,300 | unchanged | 0.00 | ||
| AUPH | aurinia pharmaceuticals inc | 2.53 | 3,969,830 | 33,624,500 | unchanged | 0.00 | ||
| CELC | celcuity inc | 2.31 | 2,294,260 | 30,628,400 | added | 83.54 | ||
| zenas biopharma inc | 1.99 | 2,733,720 | 26,489,700 | added | 4.58 | |||
| GOSS | gossamer bio inc | 1.68 | 18,093,000 | 22,254,400 | unchanged | 0.00 | ||
| BHG | neuehealth inc | 1.42 | 2,726,920 | 18,815,700 | unchanged | 0.00 | ||
| PHAT | phathom pharmaceuticals inc | 1.42 | 1,960,170 | 18,798,000 | unchanged | 0.00 | ||
| korro bio inc | 1.03 | 1,090,790 | 13,624,000 | unchanged | 0.00 | |||
| CSBR | champions oncology inc | 0.95 | 1,713,720 | 12,630,100 | unchanged | 0.00 | ||
| CVRX | cvrx inc | 0.90 | 2,026,080 | 11,913,400 | unchanged | 0.00 | ||
| BDTX | black diamond therapeutics i | 0.83 | 4,448,760 | 11,032,900 | unchanged | 0.00 | ||
